Comparison of-agar dilution, microdilution, E-test, and disk diffusion methods for testing activity of cefditoren against Streptococcus pneumoniae

被引:30
作者
Kelly, LM
Jacobs, MR
Appelbaum, PC
机构
[1] Penn State Univ, Milton S Hershey Med Ctr, Dept Pathol Clin Microbiol, Hershey, PA 17033 USA
[2] Case Western Reserve Univ, Dept Pathol Clin Microbiol, Cleveland, OH 44106 USA
关键词
D O I
10.1128/JCM.37.10.3296-3299.1999
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
This study evaluated the susceptibility of pneumococci to cefditoren by agar dilution and microdilution methods (both in air) and by E-test (AB Biodisk, Solna, Sweden) and disk diffusion methods (both in CO2). By the three MIC tests, the MICs at which 50 and 90% of isolates were inhibited (MIC(50)s and MIC(90)s) were, respectively, as follows (in micrograms per milliliter): for the 65 penicillin-susceptible strains tested, 0.016 and 0.03 (by agar dilution), 0.016 and 0.03 (by microdilution), and 0.016 and 0.03 (by E test); for the 68 penicillin-intermediate strains tested, 0.125 and 0.5 (by agar dilution), 0.125 and 0.5 (by microdilution), and 0.25 and 0.5 (by E test); and for the 67 penicillin-resistant strains tested, 1.0 and 1.0 (by agar dilution), 0.5 and 1.0 (by microdilution), and 1.0 and 1.0 (by E test). With tentative cefditoren breakpoints (in micrograms per milliliter) of less than or equal to 2.0 (susceptible), 4.0 (intermediate), and greater than or equal to 8.0 (resistant), all strains were susceptible to cefditoren by agar, microdilution, and E-test results; with breakpoints of less than or equal to 1.0, 2.0, and greater than or equal to 4.0 mu g/ml, 97% of strains were cefditoren susceptible by agar dilution results, 98% were susceptible by microdilution results, and 99% were susceptible by E-test results, When microdilution and E-test results were compared to those from the reference agar dilution method, 191 (95.5%) and 183 (91.5%) of strains gave essential agreement (+/-1 log, dilution); 8 (2.7%) minor discrepancies were found for both methods with a breakpoint of less than or equal to 1.0 mu g/ml, and no discrepancies were found with a breakpoint of less than or equal to 2.0 mu g/ml. Disk test results (breakpoint, less than or equal to 1.0 mu g/ml) produced 2 major and 30 minor errors, with corresponding zone diameters (in millimeters) of greater than or equal to 20 (susceptible), 17 to 19 (intermediate), and less than or equal to 16 (resistant); a less than or equal to 2.0-mu g/ml breakpoint yielded zone diameters of greater than or equal to 16 mm (susceptible). All three methods for testing the MIC of cefditoren showed excellent correlation.
引用
收藏
页码:3296 / 3299
页数:4
相关论文
共 19 条
[11]   INVITRO ANTIBACTERIAL ACTIVITY OF ME1207, A NEW ORAL CEPHALOSPORIN [J].
MIYAZAKI, S ;
MIYAZAKI, Y ;
TSUJI, A ;
NISHIDA, M ;
GOTO, S .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1991, 35 (08) :1691-1694
[12]  
MULFORD D, 1999, COMMUNICATION
[13]   GEOGRAPHIC-DISTRIBUTION OF PENICILLIN-RESISTANT CLONES OF STREPTOCOCCUS-PNEUMONIAE - CHARACTERIZATION BY PENICILLIN-BINDING PROTEIN PROFILE, SURFACE PROTEIN-A TYPING, AND MULTILOCUS ENZYME ANALYSIS [J].
MUNOZ, R ;
MUSSER, JM ;
CRAIN, M ;
BRILES, DE ;
MARTON, A ;
PARKINSON, AJ ;
SORENSEN, U ;
TOMASZ, A .
CLINICAL INFECTIOUS DISEASES, 1992, 15 (01) :112-118
[14]  
NEGRI MC, 1994, 34 INT C ANT AG CHEM, P28
[15]   ACTIVITY OF ORAL ANTIBIOTICS IN MIDDLE-EAR AND SINUS INFECTIONS CAUSED BY PENICILLIN-RESISTANT STREPTOCOCCUS-PNEUMONIAE - IMPLICATIONS FOR TREATMENT [J].
NELSON, CT ;
MASON, EO ;
KAPLAN, SL .
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1994, 13 (07) :585-589
[16]  
SHIMADA K, 1989, 29 INT C ANT AG CHEM, P162
[17]   Time-kill studies on susceptibility of nine penicillin-susceptible and -resistant pneumococci to cefditoren compared with nine other beta-lactams [J].
Spangler, SK ;
Jacobs, MR ;
Appelbaum, PC .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1997, 39 (02) :141-148
[18]   Activities of RPR 106972 (a new oral streptogramin), cefditoren (a new oral cephalosporin), two new oxazolidinones (U-100592 and U-100766), and other oral and parenteral agents against 203 penicillin-susceptible and -resistant pneumococci [J].
Spangler, SK ;
Jacobs, MR ;
Appelbaum, PC .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1996, 40 (02) :481-484
[19]   INVITRO AND INVIVO ANTIBACTERIAL ACTIVITIES OF ME1207, A NEW ORAL CEPHALOSPORIN [J].
TAMURA, A ;
OKAMOTO, R ;
YOSHIDA, T ;
YAMAMOTO, H ;
KONDO, S ;
INOUE, M ;
MITSUHASHI, S .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1988, 32 (09) :1421-1426